Combination eravacycline therapy for ventilator-associated pneumonia due to carbapenem-resistant Acinetobacter baumannii in patients with COVID-19: A case series.

Melissa N W JacksonWenjing WeiNorman S MangBonnie C ProkeschJessica K Ortwine

Published in: Pharmacotherapy (2024)

With limited viable salvage treatment options, combination eravacycline therapy showed favorable microbiological and clinical outcomes in patients with CRAB pneumonia. In light of this, eravacycline could be considered as a potential treatment option when designing CRAB pneumonia salvage therapy regimens.

Keyphrases

acinetobacter baumannii
multidrug resistant
drug resistant
pseudomonas aeruginosa
community acquired pneumonia
stem cells
intensive care unit
mesenchymal stem cells
cystic fibrosis
climate change
smoking cessation
acute respiratory distress syndrome